Entero Healthcare [ENTERO] vs Zenlabs Ethica [ZENLABS] Detailed Stock Comparison

Entero Healthcare
NSE
Loading...

Zenlabs Ethica
BSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Entero Healthcare wins in 11 metrics, Zenlabs Ethica wins in 6 metrics, with 0 ties. Entero Healthcare appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Entero Healthcare | Zenlabs Ethica | Better |
---|---|---|---|
P/E Ratio (TTM) | 51.29 | 74.93 | Entero Healthcare |
Price-to-Book Ratio | 3.04 | 1.91 | Zenlabs Ethica |
Debt-to-Equity Ratio | 21.76 | 121.85 | Entero Healthcare |
PEG Ratio | 1.34 | N/A | N/A |
EV/EBITDA | 27.52 | 11.45 | Zenlabs Ethica |
Profit Margin (TTM) | 1.90% | 0.52% | Entero Healthcare |
Operating Margin (TTM) | 2.94% | 2.16% | Entero Healthcare |
EBITDA Margin (TTM) | 2.94% | 2.16% | Entero Healthcare |
Return on Equity | 5.36% | 2.58% | Entero Healthcare |
Return on Assets (TTM) | 3.51% | 0.66% | Entero Healthcare |
Free Cash Flow (TTM) | $-881.78M | $38.14M | Zenlabs Ethica |
1-Year Return | -2.62% | -21.03% | Entero Healthcare |
Price-to-Sales Ratio (TTM) | 0.97 | 0.40 | Zenlabs Ethica |
Enterprise Value | $53.62B | $313.66M | Entero Healthcare |
EV/Revenue Ratio | 0.99 | 0.62 | Zenlabs Ethica |
Gross Profit Margin (TTM) | 9.94% | 32.99% | Zenlabs Ethica |
Revenue per Share (TTM) | $1,242 | $78 | Entero Healthcare |
Earnings per Share (Diluted) | $23.52 | $0.41 | Entero Healthcare |
Beta (Stock Volatility) | N/A | -0.77 | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Entero Healthcare vs Zenlabs Ethica Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Entero Healthcare | -0.12% | -4.11% | -3.93% | -17.10% | -1.97% | -15.97% |
Zenlabs Ethica | -2.01% | -6.82% | -13.83% | -3.70% | -8.71% | -23.24% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Entero Healthcare | -2.62% | 4.95% | 4.95% | 4.95% | 4.95% | 4.95% |
Zenlabs Ethica | -21.03% | -32.56% | 20.71% | 327.26% | 30.06% | 494.20% |
Performance & Financial Health Analysis: Entero Healthcare vs Zenlabs Ethica
Metric | ENTERO | ZENLABS |
---|---|---|
Market Information | ||
Market Cap | ₹52.49B | ₹199.99M |
Market Cap Category | Mid cap | Small cap |
10 Day Avg. Volume | 62,514 | 1,656 |
90 Day Avg. Volume | 76,993 | 9,181 |
Last Close | ₹1,206.40 | ₹30.72 |
52 Week Range | ₹1,080.00 - ₹1,584.25 | ₹27.33 - ₹52.10 |
% from 52W High | -23.85% | -41.04% |
All-Time High | ₹1,584.25 (Nov 04, 2024) | ₹134.90 (Sep 10, 2018) |
% from All-Time High | -23.85% | -77.23% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.28% | -0.07% |
Quarterly Earnings Growth | 0.38% | -0.20% |
Financial Health | ||
Profit Margin (TTM) | 0.02% | 0.01% |
Operating Margin (TTM) | 0.03% | 0.02% |
Return on Equity (TTM) | 0.05% | 0.03% |
Debt to Equity (MRQ) | 21.76 | 121.85 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | ₹396.70 | ₹16.09 |
Cash per Share (MRQ) | ₹73.09 | ₹2.70 |
Operating Cash Flow (TTM) | ₹-1,784,970,000 | ₹4.79M |
Levered Free Cash Flow (TTM) | ₹948.20M | ₹2.69M |
Dividends | ||
Last 12-Month Dividend Yield | N/A | N/A |
Last 12-Month Dividend | N/A | ₹0.00 |
Valuation & Enterprise Metrics Analysis: Entero Healthcare vs Zenlabs Ethica
Metric | ENTERO | ZENLABS |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 51.29 | 74.93 |
Forward P/E | 23.58 | N/A |
PEG Ratio | 1.34 | N/A |
Price to Sales (TTM) | 0.97 | 0.40 |
Price to Book (MRQ) | 3.04 | 1.91 |
Market Capitalization | ||
Market Capitalization | ₹52.49B | ₹199.99M |
Enterprise Value | ₹53.62B | ₹313.66M |
Enterprise Value Metrics | ||
Enterprise to Revenue | 0.99 | 0.62 |
Enterprise to EBITDA | 27.52 | 11.45 |
Risk & Other Metrics | ||
Beta | N/A | -0.77 |
Book Value per Share (MRQ) | ₹396.70 | ₹16.09 |
Financial Statements Comparison: Entero Healthcare vs Zenlabs Ethica
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | ENTERO | ZENLABS |
---|---|---|
Revenue/Sales | ₹14.04B | ₹129.85M |
Cost of Goods Sold | ₹12.64B | ₹87.02M |
Gross Profit | ₹1.40B | ₹42.84M |
Research & Development | N/A | N/A |
Operating Income (EBIT) | ₹412.02M | ₹3.41M |
EBITDA | ₹558.96M | ₹6.97M |
Pre-Tax Income | ₹363.63M | ₹1.55M |
Income Tax | ₹61.31M | ₹644,000 |
Net Income (Profit) | ₹302.32M | ₹906,000 |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | ENTERO | ZENLABS |
---|---|---|
Cash & Equivalents | ₹2.29B | ₹17.87M |
Total Current Assets | ₹20.76B | ₹373.48M |
Total Current Liabilities | ₹8.45B | ₹281.23M |
Long-Term Debt | ₹670.18M | ₹5.68M |
Total Shareholders Equity | ₹17.70B | ₹104.25M |
Retained Earnings | N/A | N/A |
Property, Plant & Equipment | ₹1.32B | ₹22.92M |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | ENTERO | ZENLABS |
---|---|---|
Operating Cash Flow | N/A | N/A |
Capital Expenditures | N/A | N/A |
Free Cash Flow | N/A | N/A |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | ENTERO | ZENLABS |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 62,514 | 1,656 |
Average Daily Volume (90 Day) | 76,993 | 9,181 |
Shares Outstanding | 43.51M | 6.51M |
Float Shares | 13.64M | 2.18M |
% Held by Insiders | 0.63% | 0.65% |
% Held by Institutions | 0.22% | 0.00% |
Dividend Analysis & Yield Comparison: Entero Healthcare vs Zenlabs Ethica
Metric | ENTERO | ZENLABS |
---|---|---|
Last 12-Month Dividend | N/A | ₹0.00 |
Last 12-Month Dividend Yield | N/A | N/A |
3-Year Avg Annual Dividend | N/A | ₹0.08 |
3-Year Avg Dividend Yield | N/A | 0.57% |
3-Year Total Dividends | N/A | ₹0.25 |
Ex-Dividend Date | N/A | Jul 29, 2022 |